Missing Links?: 1439 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 11926,
Authors: 23462,
Journals: 1381,
Outer References: 268081,
Words: 10857
Collection span: 1954 - 2005
View: Overview. Sorted by journal name.
Page 33 of 120: 1 11 21 [ 31 32 33 34 35 36 37 38 39 40 ] 41 51 61 71 81 91 | 101
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
---|---|---|---|---|---|
3201 | 2 | 28 | 6644 1986 CLINICAL ENDOCRINOLOGY 25 (2): 127-132 RASMUSSEN DD; LIU JH; SWARTZ WH; TUEROS VS; YEN SSC HUMAN-FETAL HYPOTHALAMIC GNRH NEUROSECRETION - DOPAMINERGIC REGULATION INVITRO | 3 | 9 |
3202 | 3 | 24 | 6645 1986 CLINICAL ENDOCRINOLOGY 25 (2): 165-172 LANG U; THEINTZ G; RIVEST RW; SIZONENKO PC NOCTURNAL URINARY MELATONIN EXCRETION AND PLASMA-CORTISOL LEVELS IN CHILDREN AND ADOLESCENTS AFTER A SINGLE ORAL DOSE OF DEXAMETHASONE | 0 | 11 |
3203 | 6 | 17 | 6646 1986 CLINICAL ENDOCRINOLOGY 25 (3): 283-292 KULIN HE; SANTNER SJ THE ASSESSMENT OF DIMINISHED TESTICULAR FUNCTION IN BOYS OF PUBERTAL AGE | 1 | 4 |
3204 | 4 | 29 | 6647 1986 CLINICAL ENDOCRINOLOGY 25 (4): 363-371 BOIZEL R; DEPERETTI E; CATHIARD AM; HALIMI S; BOST M; et al. PATTERN OF PLASMA-LEVELS OF CORTISOL, DEHYDROEPIANDROSTERONE AND PREGNENOLONE SULFATE IN NORMAL SUBJECTS AND IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA DURING ACTH INFUSION | 0 | 9 |
3205 | 3 | 17 | 6648 1986 CLINICAL ENDOCRINOLOGY 25 (5): 549-554 MIYAI K; ICHIHARA K; KONDO K; MORI S ASYMPTOMATIC HYPERPROLACTINEMIA AND PROLACTINOMA IN THE GENERAL-POPULATION - MASS-SCREENING BY PAIRED ASSAYS OF SERUM PROLACTIN | 5 | 67 |
3206 | 4 | 26 | 6649 1986 CLINICAL ENDOCRINOLOGY 25 (6): 721-728 ROJDMARK S DOES SHORT-TERM FASTING DESENSITIZE HUMAN SOMATOTROPHS TO ORAL L-DOPA STIMULATION | 0 | 5 |
3207 | 9 | 23 | 6972 1987 CLINICAL ENDOCRINOLOGY 26 (1): 117-123 ROSS RJM; BORGES F; GROSSMAN A; SMITH R; NGAHFOONG L; et al. GROWTH-HORMONE PRETREATMENT IN MAN BLOCKS THE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE - EVIDENCE FOR A DIRECT EFFECT OF GROWTH-HORMONE | 52 | 83 |
3208 | 21 | 139 | 6973 1987 CLINICAL ENDOCRINOLOGY 26 (3): 361-384 CLAYTON RN GONADOTROPIN-RELEASING-HORMONE - FROM PHYSIOLOGY TO PHARMACOLOGY | 0 | 38 |
3209 | 5 | 18 | 6974 1987 CLINICAL ENDOCRINOLOGY 26 (5): 589-595 PAGE MD; KOPPESCHAAR HPF; EDWARDS CA; DIEGUEZ C; SCANLON MF ADDITIVE EFFECTS OF GROWTH-HORMONE RELEASING-FACTOR AND INSULIN HYPOGLYCEMIA ON GROWTH-HORMONE RELEASE IN MAN | 11 | 53 |
3210 | 7 | 18 | 6975 1987 CLINICAL ENDOCRINOLOGY 27 (1): 85-90 VALCAVI R; DIEGUEZ C; PREECE M; TAYLOR A; PORTIOLI I; et al. EFFECT OF THYROXINE REPLACEMENT THERAPY ON PLASMA INSULIN-LIKE GROWTH FACTOR-I LEVELS AND GROWTH-HORMONE RESPONSES TO GROWTH-HORMONE RELEASING-FACTOR IN HYPOTHYROID PATIENTS | 11 | 45 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3211 | 8 | 20 | 6976 1987 CLINICAL ENDOCRINOLOGY 27 (2): 155-161 ROSS RJM; GROSSMAN A; DAVIES PSW; SAVAGE MO; BESSER GM STILBESTROL PRETREATMENT OF CHILDREN WITH SHORT STATURE DOES NOT AFFECT THE GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE | 6 | 16 |
3212 | 4 | 20 | 6977 1987 CLINICAL ENDOCRINOLOGY 27 (3): 289-295 THOMAS DJB; TOUZEL R; CHARLESWORTH M; WASS JAH; BESSER GM HYPERPROLACTINEMIA AND MICROADENOMAS IN PRIMARY HYPOTHYROIDISM | 3 | 15 |
3213 | 8 | 46 | 6978 1987 CLINICAL ENDOCRINOLOGY 27 (5): 581-591 HINDMARSH P; SMITH PJ; BROOK CGD; MATTHEWS DR THE RELATIONSHIP BETWEEN HEIGHT VELOCITY AND GROWTH-HORMONE SECRETION IN SHORT PREPUBERTAL CHILDREN | 50 | 170 |
3214 | 3 | 21 | 6979 1987 CLINICAL ENDOCRINOLOGY 27 (6): 635-642 HORROCKS PM; LONDON DR EFFECTS OF LONG-TERM DEXAMETHASONE TREATMENT IN ADULT PATIENTS WITH CONGENITAL ADRENAL-HYPERPLASIA | 1 | 7 |
3215 | 0 | 23 | 6980 1987 CLINICAL ENDOCRINOLOGY 27 (6): 643-648 INAUDI P; BERNABEI A; GIOFFRE W; FRANCHI F; MAZZULLO G; et al. PLASMA AND CYST FLUID LEVELS OF DELTA-5 AND DELTA-4 STEROID-HORMONES IN WOMEN WITH GROSS CYSTIC BREAST DISEASE | 0 | 3 |
3216 | 4 | 21 | 6981 1987 CLINICAL ENDOCRINOLOGY 27 (6): 727-733 ROSS RJM; TSAGARAKIS S; GROSSMAN A; NHAGAFOONG L; TOUZEL RJ; et al. GH FEEDBACK OCCURS THROUGH MODULATION OF HYPOTHALAMIC SOMATOSTATIN UNDER CHOLINERGIC CONTROL - STUDIES WITH PYRIDOSTIGMINE AND GHRH | 21 | 118 |
3217 | 10 | 23 | 7282 1988 CLINICAL ENDOCRINOLOGY 28 (1): 75-82 CRISTIANO AM; MUNABI A; ELSABBAGH H; CASSORLA F; SHERINS RJ PROLACTIN RESPONSE TO METOCLOPRAMIDE DOES NOT DISTINGUISH PATIENTS WITH HYPOGONADOTROPIC HYPOGONADISM FROM DELAYED PUBERTY | 1 | 1 |
3218 | 54 | 268 | 7283 1988 CLINICAL ENDOCRINOLOGY 28 (1): 109-143 DIEGUEZ C; PAGE MD; SCANLON MF GROWTH-HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES | 19 | 239 |
3219 | 8 | 23 | 7284 1988 CLINICAL ENDOCRINOLOGY 28 (5): 479-486 PRINGLE PJ; STANHOPE R; HINDMARSH P; BROOK CGD ABNORMAL PUBERTAL DEVELOPMENT IN PRIMARY HYPOTHYROIDISM | 11 | 28 |
3220 | 1 | 21 | 7285 1988 CLINICAL ENDOCRINOLOGY 28 (5): 515-524 DONS RF; ROSSELET P; PASTAKIA B; DOPPMAN J; GORDEN P ARTHROPATHY IN ACROMEGALIC PATIENTS BEFORE AND AFTER TREATMENT - A LONG-TERM FOLLOW-UP-STUDY | 2 | 20 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3221 | 9 | 21 | 7286 1988 CLINICAL ENDOCRINOLOGY 28 (5): 543-549 BRAIN C; HINDMARSH PC; BROOK CGD; MATTHEWS DR CONTINUOUS SUBCUTANEOUS GROWTH-HORMONE RELEASING-FACTOR ANALOG AUGMENTS GROWTH-HORMONE SECRETION IN NORMAL-MALE SUBJECTS WITH NO DESENSITIZATION OF THE SOMATOTROPH | 11 | 23 |
3222 | 7 | 33 | 7287 1988 CLINICAL ENDOCRINOLOGY 29 (1): 17-28 ULLOAAGUIRRE A; MENDEZ JP; GONZALEZCASTILLO A; CARRANZALIRA S; GARZAFLORES J; et al. CHANGES IN THE RESPONSIVENESS OF LUTEINIZING-HORMONE SECRETION TO INFUSION OF THE OPIOID ANTAGONIST NALOXONE THROUGHOUT MALE SEXUAL-MATURATION | 2 | 15 |
3223 | 10 | 30 | 7288 1988 CLINICAL ENDOCRINOLOGY 29 (4): 427-436 BUCHANAN CR; STANHOPE R; ADLARD P; JONES J; GRANT DB; et al. GONADOTROPIN, GROWTH-HORMONE AND PROLACTIN SECRETION IN CHILDREN WITH PRIMARY HYPOTHYROIDISM | 6 | 18 |
3224 | 3 | 17 | 7289 1988 CLINICAL ENDOCRINOLOGY 29 (5): 503-508 HARRIS PE; PERRY L; CHARD T; CHAUDRY L; COOKE BA; et al. IMMUNOREACTIVE HUMAN CHORIONIC-GONADOTROPIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA | 0 | 8 |
3225 | 9 | 36 | 7547 1989 CLINICAL ENDOCRINOLOGY 30 (1): 1-12 BOYAGES S; HALPERN JP; MABERLY GF; EASTMAN CJ; CARR P; et al. EFFECTS OF PROTRACTED HYPOTHYROIDISM ON PITUITARY-FUNCTION AND STRUCTURE IN ENDEMIC CRETINISM | 1 | 12 |
3226 | 9 | 18 | 7548 1989 CLINICAL ENDOCRINOLOGY 30 (1): 65-75 SERRI O; SOMMA M; RASIO E; BRAZEAU P GROWTH HORMONE-RELEASING FACTOR INCREASES SERUM PROLACTIN CONCENTRATIONS IN NORMAL SUBJECTS AND IN PATIENTS WITH PITUITARY-ADENOMAS | 0 | 6 |
3227 | 8 | 21 | 7549 1989 CLINICAL ENDOCRINOLOGY 30 (4): 367-377 DEVESA J; LIMA L; LOIS N; FRAGA C; LECHUGA MJ; et al. REASONS FOR THE VARIABILITY IN GROWTH-HORMONE (GH) RESPONSES TO GHRH CHALLENGE - THE ENDOGENOUS HYPOTHALAMIC-SOMATOTROPH RHYTHM (HSR) | 23 | 69 |
3228 | 2 | 29 | 7550 1989 CLINICAL ENDOCRINOLOGY 30 (4): 413-420 EDGE JA; HOURD P; EDWARDS R; DUNGER DB URINARY GROWTH-HORMONE DURING PUBERTY IN NORMAL AND DIABETIC CHILDREN | 2 | 27 |
3229 | 7 | 31 | 7551 1989 CLINICAL ENDOCRINOLOGY 30 (5): 587-596 BUTLER GE; WALKER RF; WALKER RV; TEAGUE P; RIADFAHMY D; et al. SALIVARY TESTOSTERONE LEVELS AND THE PROGRESS OF PUBERTY IN THE NORMAL BOY | 1 | 34 |
3230 | 6 | 21 | 7552 1989 CLINICAL ENDOCRINOLOGY 31 (3): 363-373 LITTLEY MD; SHALET SM; BEARDWELL CG; ROBINSON EL; SUTTON ML RADIATION-INDUCED HYPOPITUITARISM IS DOSE-DEPENDENT | 16 | 88 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3231 | 9 | 29 | 7553 1989 CLINICAL ENDOCRINOLOGY 31 (3): 375-387 YEH J; REBAR RW; LIU JH; YEN SSC PITUITARY-FUNCTION IN ISOLATED GONADOTROPIN-DEFICIENCY | 0 | 6 |
3232 | 9 | 30 | 7554 1989 CLINICAL ENDOCRINOLOGY 31 (5): 551-564 WENNINK JMB; DELEMARREVANDEWAAL HA; SCHOEMAKER R; SCHOEMAKER H; SCHOEMAKER J LUTEINIZING-HORMONE AND FOLLICLE-STIMULATING HORMONE-SECRETION PATTERNS IN BOYS THROUGHOUT PUBERTY MEASURED USING HIGHLY SENSITIVE IMMUNORADIOMETRIC ASSAYS | 7 | 25 |
3233 | 8 | 28 | 7555 1989 CLINICAL ENDOCRINOLOGY 31 (5): 581-590 KUHN JM; REZNIK Y; MAHOUDEAU JA; COURTOIS H; LEFEBVRE H; et al. HCG TEST IN GYNECOMASTIA - FURTHER STUDY | 1 | 5 |
3234 | 5 | 27 | 7830 1990 CLINICAL ENDOCRINOLOGY 32 (4): 485-490 FUKAZAWA H; SAKURADA T; YOSHIDA K; KAISE N; KAISE K; et al. THYROID-FUNCTION IN PATIENTS WITH MYOTONIC-DYSTROPHY | 1 | 6 |
3235 | 10 | 21 | 7831 1990 CLINICAL ENDOCRINOLOGY 33 (2): 239-248 ROSS RJM; KIRK JMW; TSAGARAKIS S; TRAINER PJ; CICCARELLI E; et al. SUBCUTANEOUS GROWTH HORMONE-RELEASING HORMONE AUGMENTS PULSATILE NOCTURNAL GH RELEASE IN GH-INSUFFICIENT CHILDREN, BUT MAY ALSO RAISE BASAL GH SECRETION | 4 | 5 |
3236 | 7 | 39 | 7832 1990 CLINICAL ENDOCRINOLOGY 33 (4): 525-537 BURKE CW; ADAMS CBT; ESIRI MM; MORRIS C; BEVAN JS TRANSSPHENOIDAL SURGERY FOR CUSHINGS-DISEASE - DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME | 14 | 76 |
3237 | 12 | 37 | 7833 1990 CLINICAL ENDOCRINOLOGY 33 (6): 719-727 ROSSMANITH WG; SWARTZ WH; TUEROS VS; YEN SSC; RASMUSSEN DD PULSATILE GNRH-STIMULATED LH-RELEASE FROM THE HUMAN FETAL PITUITARY INVITRO - SEX-ASSOCIATED DIFFERENCES | 1 | 4 |
3238 | 5 | 114 | 7834 1990 CLINICAL ENDOCRINOLOGY 33 (6): 787-807 SHARPE RM INTRATESTICULAR CONTROL OF STEROIDOGENESIS | 4 | 66 |
3239 | 2 | 21 | 8051 1991 CLINICAL ENDOCRINOLOGY 34 (1): 5-11 HOFLAND LJ; VELKENIERS B; VANKOETSVELD PM; HOOGHEPETERS EL; LAMBERTS SWJ THE RELATIONSHIP BETWEEN GROWTH-HORMONE (GH) MESSENGER-RIBONUCLEIC-ACID LEVELS AND HORMONE-RELEASE FROM INDIVIDUAL CELLS DERIVED FROM HUMAN GH-SECRETING PITUITARY-ADENOMAS | 1 | 11 |
3240 | 9 | 27 | 8052 1991 CLINICAL ENDOCRINOLOGY 34 (1): 13-17 SURI D; HINDMARSH PC; MATTHEWS DR; BRAIN CE; BROOK CGD THE PITUITARY-GLAND IS CAPABLE OF RESPONDING TO 2 SUCCESSIVE DOSES OF GROWTH-HORMONE RELEASING HORMONE (GHRH) | 5 | 13 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3241 | 3 | 14 | 8053 1991 CLINICAL ENDOCRINOLOGY 34 (3): 187-190 SALARDI S; ORSINI LF; CACCIARI E; RIGHETTI F; DONATI S; et al. GROWTH-HORMONE, INSULIN-LIKE GROWTH FACTOR-I, INSULIN AND C-PEPTIDE DURING HUMAN FETAL LIFE - INUTERO STUDY | 7 | 15 |
3242 | 5 | 37 | 8054 1991 CLINICAL ENDOCRINOLOGY 34 (4): 265-274 MULLIS PE; PATEL MS; BRICKELL PM; HINDMARSH PC; BROOK CGD GROWTH-CHARACTERISTICS AND RESPONSE TO GROWTH-HORMONE THERAPY IN PATIENTS WITH HYPOCHONDROPLASIA - GENETIC-LINKAGE OF THE INSULIN-LIKE GROWTH FACTOR-I GENE AT CHROMOSOME-12Q23 TO THE DISEASE IN A SUBGROUP OF THESE PATIENTS | 1 | 20 |
3243 | 11 | 25 | 8055 1991 CLINICAL ENDOCRINOLOGY 34 (5): 407-411 KIRK JMW; ROSS RJM; TRAINER PJ; FROUD ALJ; DAVIES SC; et al. PYRIDOSTIGMINE FAILS TO INCREASE EITHER SPONTANEOUS OR GHRH-STIMULATED GH SECRETION DURING DAY OR NIGHT IN GROWTH HORMONE-INSUFFICIENT CHILDREN | 0 | 1 |
3244 | 16 | 110 | 8056 1991 CLINICAL ENDOCRINOLOGY 34 (5): 417-427 HINDMARSH PC; BRIDGES NA; BROOK CGD WIDER INDICATIONS FOR TREATMENT WITH BIOSYNTHETIC HUMAN GROWTH-HORMONE IN CHILDREN | 7 | 29 |
3245 | 3 | 28 | 8057 1991 CLINICAL ENDOCRINOLOGY 34 (6): 477-483 COUZINET B; LAHLOU N; THOMAS G; THALABARD JC; BOUCHARD P; et al. EFFECTS OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST AND AGONIST ON THE PULSATILE RELEASE OF GONADOTROPINS AND ALPHA-SUBUNIT IN POSTMENOPAUSAL WOMEN | 3 | 23 |
3246 | 2 | 26 | 8058 1991 CLINICAL ENDOCRINOLOGY 34 (6): 485-491 MARTINEZMORA J; SAEZ JM; TORAN N; ISNARD R; PEREZIRIBARNE MM; et al. MALE PSEUDOHERMAPHRODITISM DUE TO LEYDIG-CELL AGENESIA AND ABSENCE OF TESTICULAR LH RECEPTORS | 6 | 17 |
3247 | 9 | 86 | 8059 1991 CLINICAL ENDOCRINOLOGY 34 (6): 507-513 ATKINSON AB THE TREATMENT OF CUSHINGS-SYNDROME | 7 | 33 |
3248 | 15 | 39 | 8060 1991 CLINICAL ENDOCRINOLOGY 35 (2): 129-135 LIMA L; ARCE V; DIAZ MJ; TRESGUERRES JAF; DEVESA J CLONIDINE PRETREATMENT MODIFIES THE GROWTH-HORMONE SECRETORY PATTERN INDUCED BY SHORT-TERM CONTINUOUS GRF INFUSION IN NORMAL MAN | 0 | 11 |
3249 | 5 | 22 | 8061 1991 CLINICAL ENDOCRINOLOGY 35 (2): 141-144 VALCAVI R; DIEGUEZ C; ZINI M; PAGE MD; DOTTI C; et al. EFFECT OF PYRIDOSTIGMINE AND PIRENZEPINE ON GH RESPONSES TO GHRH IN HYPERTHYROID PATIENTS | 4 | 16 |
3250 | 14 | 51 | 8062 1991 CLINICAL ENDOCRINOLOGY 35 (4): 353-360 HINDMARSH PC; BRAIN CE; ROBINSO; N ICAF; MATTHEWS DR; et al. THE INTERACTION OF GROWTH-HORMONE RELEASING HORMONE AND SOMATOSTATIN IN THE GENERATION OF A GH PULSE IN MAN | 16 | 56 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3251 | 9 | 47 | 8313 1992 CLINICAL ENDOCRINOLOGY 36 (3): 247-253 HAEUSLER G; FRISCH H GROWTH-HORMONE TREATMENT IN TURNERS SYNDROME - SHORT AND LONG-TERM EFFECTS ON ENTABOLIC PARAMETERS | 2 | 7 |
3252 | 3 | 36 | 8314 1992 CLINICAL ENDOCRINOLOGY 36 (4): 405-410 ARAN O; GALATZER A; KAULI R; NAGELBERG N; ROBICSEK Y; et al. SOCIAL, EDUCATIONAL AND VOCATIONAL STATUS OF 48 YOUNG-ADULT FEMALES WITH GONADAL-DYSGENESIS | 1 | 5 |
3253 | 10 | 20 | 8315 1992 CLINICAL ENDOCRINOLOGY 37 (1): 73-77 MOREIRA AC; CASTRO M; MACIEL LMZ; HILTNER AN LUTEINIZING-HORMONE RESPONSE TO CLOMIPHENE CITRATE IN CENTRAL PRECOCIOUS PUBERTY | 1 | 1 |
3254 | 3 | 30 | 8316 1992 CLINICAL ENDOCRINOLOGY 37 (3): 240-248 HOFLAND LJ; VELKENIERS B; VANDERLELY AJ; VANKOETSVELD PM; KAZEMZADEH M; et al. LONG-TERM INVITRO TREATMENT OF HUMAN GROWTH-HORMONE (GH)-SECRETING PITUITARY-ADENOMA CELLS WITH OCTREOTIDE CAUSES ACCUMULATION OF INTRACELLULAR GH AND GH MESSENGER-RNA LEVELS | 1 | 12 |
3255 | 7 | 29 | 8317 1992 CLINICAL ENDOCRINOLOGY 37 (4): 365-372 LEITE V; COSBY H; SOBRINHO LG; FRESNOZA A; SANTOS MA; et al. CHARACTERIZATION OF BIG, BIG PROLACTIN IN PATIENTS WITH HYPERPROLACTINEMIA | 6 | 53 |
3256 | 10 | 41 | 8530 1993 CLINICAL ENDOCRINOLOGY 38 (1): 79-86 MCCANCE DR; GORDON DS; FANNIN TF; HADDEN DR; KENNEDY L; et al. ASSESSMENT OF ENDOCRINE FUNCTION AFTER TRANSSPHENOIDAL SURGERY FOR CUSHINGS-DISEASE | 9 | 44 |
3257 | 8 | 51 | 8531 1993 CLINICAL ENDOCRINOLOGY 38 (2): 149-157 ISMAIL IS; SCANLON MF; PETERS JR CHOLINERGIC CONTROL OF GROWTH-HORMONE (GH) RESPONSES TO GH-RELEASING HORMONE IN INSULIN-DEPENDENT DIABETICS - EVIDENCE FOR ATTENUATED HYPOTHALAMIC SOMATOSTATINERGIC TONE AND DECREASED GH AUTOFEEDBACK | 2 | 15 |
3258 | 3 | 26 | 8532 1993 CLINICAL ENDOCRINOLOGY 38 (2): 197-201 LOBACCARO JM; MEDLEJ R; BERTA P; BELON C; GALIFER RB; et al. PCR ANALYSIS AND SEQUENCING OF THE SRY SEX DETERMINING GENE IN 4 PATIENTS WITH BILATERAL CONGENITAL ANORCHIA | 2 | 5 |
3259 | 2 | 27 | 8533 1993 CLINICAL ENDOCRINOLOGY 38 (3): 265-272 MUNE T; MORITA H; YASUDA K; MURAYAMA M; YAMAKITA N; et al. ELEVATED PLASMA 19-HYDROXYANDROSTENEDIONE LEVELS IN CUSHINGS-DISEASE - STIMULATION WITH ACTH AND INHIBITION WITH METYRAPONE | 0 | 4 |
3260 | 9 | 28 | 8534 1993 CLINICAL ENDOCRINOLOGY 39 (1): 85-89 BOURGUIGNON JP; GERARD A; DEBYDUPONT G; FRANCHIMONT P EFFECTS OF GROWTH-HORMONE THERAPY ON THE DEVELOPMENTAL-CHANGES OF FOLLICLE-STIMULATING-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I SERUM CONCENTRATIONS IN TURNERS-SYNDROME | 2 | 8 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3261 | 6 | 24 | 8535 1993 CLINICAL ENDOCRINOLOGY 39 (2): 201-206 SKINNER AM; CLAYTON PE; PRICE DA; ADDISON GM; SOO A URINARY GROWTH-HORMONE EXCRETION IN THE ASSESSMENT OF CHILDREN WITH DISORDERS OF GROWTH | 2 | 14 |
3262 | 2 | 35 | 8536 1993 CLINICAL ENDOCRINOLOGY 39 (2): 245-251 SPOUDEAS HA; SLATER JDH; RUMSBY G; HONOUR JW; BROOK CGD DEOXYCORTICOSTERONE, 11-BETA-HYDROXYLASE AND THE ADRENAL-CORTEX | 0 | 3 |
3263 | 5 | 49 | 8537 1993 CLINICAL ENDOCRINOLOGY 39 (3): 315-321 MCCANCE DR; RUSSELL CFJ; KENNEDY TL; HADDEN DR; KENNEDY L; et al. BILATERAL ADRENALECTOMY - LOW MORTALITY AND MORBIDITY IN CUSHINGS-DISEASE | 5 | 31 |
3264 | 9 | 99 | 8748 1994 CLINICAL ENDOCRINOLOGY 40 (2): 155-170 HOURD P; EDWARDS R CURRENT METHODS FOR THE MEASUREMENT OF GROWTH-HORMONE IN URINE | 2 | 24 |
3265 | 2 | 25 | 8749 1994 CLINICAL ENDOCRINOLOGY 40 (2): 179-185 BERATIS NG; VARVARIGOU A; MAKRI M; VAGENAKIS AG PROLACTIN, GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I IN NEWBORN CHILDREN OF SMOKING MOTHERS | 1 | 13 |
3266 | 4 | 26 | 8750 1994 CLINICAL ENDOCRINOLOGY 40 (3): 351-355 KOBAYASHI Y; MURATA A; YASUDA T; MINAGAWA M; WATAKI K; et al. SUPPRESSION OF SEX STEROIDS BY A GONADOTROPIN-RELEASING-HORMONE AGONIST INCREASES SERUM GROWTH HORMONE-BINDING PROTEIN-ACTIVITY IN GIRLS WITH CENTRAL IDIOPATHIC PRECOCIOUS PUBERTY | 4 | 8 |
3267 | 6 | 61 | 8751 1994 CLINICAL ENDOCRINOLOGY 41 (1): 1-5 SHOHAM Z; ZALEL Y; JACOBS HS THE ROLE OF GROWTH-HORMONE IN MALE-INFERTILITY | 1 | 14 |
3268 | 13 | 37 | 8752 1994 CLINICAL ENDOCRINOLOGY 41 (2): 163-168 OGILVYSTUART AL; WALLACE WHB; SHALET SM RADIATION AND NEUROREGULATORY CONTROL OF GROWTH-HORMONE SECRETION | 6 | 15 |
3269 | 6 | 23 | 8753 1994 CLINICAL ENDOCRINOLOGY 41 (3): 331-335 HOCHBERG Z; LEIBERMAN E; LANDAU H; KOREN R; ZADIK Z AGE AS A DETERMINANT OF THE IMPACT OF GROWTH-HORMONE THERAPY ON PREDICTED ADULT HEIGHT | 4 | 12 |
3270 | 7 | 27 | 8754 1994 CLINICAL ENDOCRINOLOGY 41 (3): 359-364 MINDERMANN T; WILSON CB AGE-RELATED AND GENDER-RELATED OCCURRENCE OF PITUITARY-ADENOMAS | 4 | 39 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3271 | 1 | 26 | 8755 1994 CLINICAL ENDOCRINOLOGY 41 (4): 525-530 VERHELST J; DENIS L; VANVLIET P; VANPOPPEL H; BRAECKMAN J; et al. ENDOCRINE PROFILES DURING ADMINISTRATION OF THE NEW NONSTEROIDAL ANTIANDROGEN CASODEX IN PROSTATE-CANCER | 6 | 51 |
3272 | 8 | 27 | 8756 1994 CLINICAL ENDOCRINOLOGY 41 (6): 795-800 CUNNINGHAM SK; MCKENNA TJ DISSOCIATION OF ADRENAL ANDROGEN AND CORTISOL SECRETION IN CUSHINGS-SYNDROME | 3 | 16 |
3273 | 8 | 32 | 8969 1995 CLINICAL ENDOCRINOLOGY 42 (5): 461-466 BRUNELLI VL; CHIUMELLO G; DAVID M; FOREST MG ADRENARCHE DOES NOT OCCUR IN TREATED PATIENTS WITH CONGENITAL ADRENAL-HYPERPLASIA RESULTING FROM 21-HYDROXYLASE DEFICIENCY | 3 | 4 |
3274 | 10 | 24 | 8970 1995 CLINICAL ENDOCRINOLOGY 42 (5): 467-473 PAJA M; LUCAS T; GARCIAURIA J; SALAME F; BARCELO B; et al. HYPOTHALAMIC-PITUITARY DYSFUNCTION IN PATIENTS WITH CRANIOPHARYNGIOMA | 14 | 26 |
3275 | 5 | 33 | 8971 1995 CLINICAL ENDOCRINOLOGY 42 (6): 619-626 BARTON JS; GARDINER HM; CULLEN S; HINDMARSH PC; BROOK CGD; et al. THE GROWTH AND CARDIOVASCULAR EFFECTS OF HIGH-DOSE GROWTH-HORMONE THERAPY IN IDIOPATHIC SHORT STATURE | 1 | 14 |
3276 | 10 | 18 | 8972 1995 CLINICAL ENDOCRINOLOGY 42 (6): 641-646 CAVALLO A; RICHARDS GE; BUSEY S; MICHAELS SE A SIMPLIFIED GONADOTROPIN-RELEASING-HORMONE TEST FOR PRECOCIOUS PUBERTY | 6 | 8 |
3277 | 9 | 44 | 8973 1995 CLINICAL ENDOCRINOLOGY 43 (1): 19-28 WEBER A; TRAINER PJ; GROSSMAN AB; AFSHAR F; MEDBAK S; et al. INVESTIGATION, MANAGEMENT AND THERAPEUTIC OUTCOME IN 12 CASES OF CHILDHOOD AND ADOLESCENT CUSHINGS-SYNDROME | 19 | 37 |
3278 | 7 | 35 | 8974 1995 CLINICAL ENDOCRINOLOGY 43 (2): 133-142 HINDMARSH PC; BROOK CGD SHORT STATURE AND GROWTH-HORMONE DEFICIENCY | 1 | 7 |
3279 | 9 | 30 | 8975 1995 CLINICAL ENDOCRINOLOGY 43 (6): 741-746 Davies MC; Gulekli B; Jacobs HS Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea | 8 | 49 |
3280 | 2 | 33 | 9232 1996 CLINICAL ENDOCRINOLOGY 44 (3): 341-347 Faccenda E; Melmed S; Bevan JS; Eidne KA Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas | 0 | 25 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3281 | 9 | 48 | 9233 1996 CLINICAL ENDOCRINOLOGY 44 (5): 515-523 Juul A; Flyvbjerg A; Frystyk J; Muller J; Skakkebaek NE Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins-1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty | 6 | 48 |
3282 | 7 | 34 | 9234 1996 CLINICAL ENDOCRINOLOGY 44 (5): 541-546 Kars ME; Pijl H; Cohen AF; Frolich M; Schoemaker HC; et al. Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women | 0 | 3 |
3283 | 9 | 29 | 9235 1996 CLINICAL ENDOCRINOLOGY 45 (1): 7-12 Kanety H; Karasik A; Pariente C; Kauschansky A Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty | 5 | 9 |
3284 | 2 | 25 | 9236 1996 CLINICAL ENDOCRINOLOGY 45 (1): 33-37 RodriguezArnao J; Perry L; Besser GM; Ross RJM Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy | 1 | 26 |
3285 | 4 | 37 | 9237 1996 CLINICAL ENDOCRINOLOGY 45 (2): 171-178 AlShoumer KAS; Ali K; Anyaoku V; Niththyananthan R; Johnston DG Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism | 1 | 21 |
3286 | 3 | 28 | 9238 1996 CLINICAL ENDOCRINOLOGY 45 (3): 257-260 Savage MO; Woods KA The investigation of growth hormone insensitivity | 0 | 7 |
3287 | 8 | 27 | 9239 1996 CLINICAL ENDOCRINOLOGY 45 (3): 281-290 Maghnie M; Genovese E; Villa A; Spagnolo L; Campan R; et al. Dynamic MRI in the congenital agenesis of the neural pituitary stalk syndrome: The role of the Vascular pituitary stalk in predicting residual anterior pituitary function | 3 | 19 |
3288 | 4 | 51 | 9500 1997 CLINICAL ENDOCRINOLOGY 46 (3): 295-300 Pimentel FR; RamosDias JC; Ninno FBD; Facanha CFS; Liberman B; et al. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism | 0 | 6 |
3289 | 7 | 27 | 9501 1997 CLINICAL ENDOCRINOLOGY 46 (3): 327-332 Premawardhana LDKE; Hughes IA; Read GF; Scanlon MF Longer term outcome in females with congenital adrenal hyperplasia (CAH): The Cardiff experience | 16 | 39 |
3290 | 11 | 37 | 9502 1997 CLINICAL ENDOCRINOLOGY 46 (4): 431-437 Weber A; Clark AJL; Perry LA; Honour JW; Savage MO Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche | 11 | 20 |
# | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
3291 | 12 | 37 | 9503 1997 CLINICAL ENDOCRINOLOGY 46 (5): 571-578 OgilvyStuart AL; Stirling HF; Kelnar CJH; Savage MO; Dunger DB; et al. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone | 6 | 11 |
3292 | 8 | 37 | 9504 1997 CLINICAL ENDOCRINOLOGY 47 (3): 261-266 Bernasconi S; Street ME; Volta C; Mazzardo G; Bartolotta E; et al. Final height in non-growth hormone deficient children treated with growth hormone | 3 | 22 |
3293 | 5 | 29 | 9795 1998 CLINICAL ENDOCRINOLOGY 48 (5): 555-560 Cisternino M; Dondi E; Martinetti M; Lorini R; Salvaneschi L; et al. Exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation and evidence for CYP21B gene point mutations in true precocious puberty | 2 | 4 |
3294 | 2 | 25 | 9796 1998 CLINICAL ENDOCRINOLOGY 48 (6): 719-724 Cotterill AM; Camacho-Hubner C; Duquesnoy P; Savage MO Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature | 4 | 14 |
3295 | 6 | 23 | 9797 1998 CLINICAL ENDOCRINOLOGY 49 (1): 107-113 Nathwani NC; Hindmarsh PC; Massarano AA; Brook CGD Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids | 1 | 2 |
3296 | 7 | 29 | 9798 1998 CLINICAL ENDOCRINOLOGY 49 (2): 197-202 Lanes R; Gunczler P Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty | 11 | 18 |
3297 | 9 | 38 | 9799 1998 CLINICAL ENDOCRINOLOGY 49 (3): 363-368 Uriarte MM; Klein KO; Barnes KM; Pescovitz OH; Loriaux DL; et al. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma | 6 | 7 |
3298 | 2 | 19 | 9800 1998 CLINICAL ENDOCRINOLOGY 49 (3): 391-396 Peace KA; Orme SM; Padayatty SJ; Godfrey HPD; Belchetz PE Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication | 0 | 8 |
3299 | 3 | 24 | 9801 1998 CLINICAL ENDOCRINOLOGY 49 (6): 803-809 Ongphiphadhanakul B; Rajatanavin R; Chanprasertyothin S; Piaseu N; Chailurkit L Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males | 51 | 71 |
3300 | 6 | 24 | 9802 1998 CLINICAL ENDOCRINOLOGY 49 (6): 811-814 Reutrakul S; Ongphiphadhanakul B; Piaseu N; Krittiyawong S; Chanprasertyothin S; et al. The effects of oestrogen exposure on bone mass in male to female transsexuals | 7 | 10 |
Page 33 of 120: 1 11 21 [ 31 32 33 34 35 36 37 38 39 40 ] 41 51 61 71 81 91 | 101
Generated by:
HistCite 2005.08.29